Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 0228-2550

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 0228-2550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of Diclofenac Sodium, showing the molecular arrangement including chlorine atoms, a sodium ion, and characteristic aromatic rings with functional groups.*

FDA Label Image

1 (Image 2)

Diclofenac Sodium 50 mg delayed release oral tablets packaging label by Actavis Pharma, Inc. The carton shows the brand and generic name, strength of 50 mg, dosage form as delayed release tablets, and includes quantity information. The label design uses a combination of white, green, and orange colors with legible text for identification.*

FDA Label Image

1 (Image 3)

Diclofenac Sodium delayed-release tablet packaging label showing the 50 mg strength. The label includes the proprietary and generic name, dosage form, strength, oral route, and manufacturer Actavis Pharma, Inc. The image displays the front and side panels of the box with text and branding information.*

FDA Label Image

50mg 60s (Image 4)

Label for Diclofenac Sodium Delayed-Release Tablets USP, 50 mg strength, oral tablets. The label states prescription use only and packaging containing 60 enteric-coated tablets. Manufactured by Teva Pharmaceuticals, Parsippany, NJ. Includes storage instructions and directs users to dispense the accompanying Medication Guide.*

FDA Label Image

2 (Image 5)

Label for Diclofenac Sodium Delayed-Release Tablets, USP 75 mg, oral tablet form. The label indicates the product is prescription only, with 60 enteric-coated tablets per container. It is manufactured for Teva Pharmaceuticals, Parsippany, NJ. Instructions include dispensing the accompanying medication guide and storing at 25°C with specified temperature excursions. The label includes an NDC number and a serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.